# Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years.

> **NCT02063139** · PHASE2 · COMPLETED · sponsor: **Mundipharma Research Limited** · enrollment: 48 (actual)

## Conditions studied

- Mild Persistent Asthma

## Interventions

- **DRUG:** Flutiform 50/5 ug (2 puffs bid) pMDI
- **DRUG:** Fluticasone 50 ug (2puffs bid) pMDI
- **DRUG:** Beclometasone Autohaler 50 ug (2 puffs bid)

## Key facts

- **NCT ID:** NCT02063139
- **Lead sponsor:** Mundipharma Research Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-06
- **Final completion:** 2015-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2018-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02063139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02063139, "Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years.". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02063139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*